Phototherapy-induced hypocalcemia is hypothesized to result from blue light penetrating the infant’s skull, affecting the pineal gland, and reducing melatonin secretion (
14). Some studies have confirmed that head covering during phototherapy prevents changes in serum calcium levels (
1,
10,
12,
15,
16), whereas others have not (
3). Evidence from studies of preterm infants is very limited (
12,
17).
The absence of laboratory-confirmed hypocalcemia contrasts with previous findings (
1,
7,
12). In a study by Barekatain et al. that included preterm infants with a gestational age < 35 weeks, the prevalence of hypocalcemia among infants without head covering was approximately 30%, and head covering significantly reduced this prevalence (
12). Similarly, Ezzeldin reported prevalences of 24% among infants without head covering and 10% among infants with head covering (
10). Muhssin et al. found hypocalcemia in 6% of neonates undergoing phototherapy (
18). Our findings were consistent with those of Jain Puja, who reported a 0% incidence of hypocalcemia in term infants (
19).
Several physiological factors may explain this finding.
First, the present study included infants with a gestational age ≥ 35 weeks, who are less susceptible to hypocalcemia than populations in studies focused on very preterm infants, such as those born at < 32 weeks (
12,
17). Premature infants are at higher risk of hypocalcemia because of reduced renal tubular calcium reabsorption, inadequate absorption of calcium from milk, lower calcium stores, and thinner skin that allows greater light transmission (
19). Late preterm infants are also more susceptible to hypocalcemia, although their risk is lower than that of infants born at < 35 weeks (
3). The greatest transfer of calcium to the fetus occurs in the last trimester. The hypocalcemia threshold is also lower in preterm and late preterm infants. In this study, only 20.2% of infants were preterm, and their distribution was unbalanced: 31.1% in the group without hats versus 9.1% in the group with hats (P = 0.01). The difference in gestational age (37 weeks without hats vs. 38 weeks with hats; P = 0.046) and the difference in the number of preterm infants could introduce bias. However, subgroup analyses showed no significant differences (P > 0.05).
Second, phototherapy intensity and duration were standardized in this study: 48 hours with four to a maximum of eight fluorescent lamps. However, treatment may have been less intense and shorter than in other studies, such as that by Tawfik (
4), in which phototherapy continued for up to 72 hours, or studies in which calcium was rechecked on the day of discharge (
2,
21). Hypocalcemia may therefore appear after 72 hours of continuous phototherapy. With advances in phototherapy devices and light-emitting diode (LED) lamps, recent studies have reported numerically lower rates of hypocalcemia than older studies, including a rate of 2.5% in the 2023 study by Pereira et al. (
21). The present study used fluorescent lamps, whereas some studies used LED lamps (
2,
21). However, LED lamps may cause hypocalcemia to the same extent as fluorescent lamps, and monitoring infants receiving LED phototherapy is also reasonable (
2).
Third, hypocalcemia in this study was defined as total calcium levels ≤ 8 mg/dL for term infants and ≤ 7 mg/dL for preterm infants (
22), consistent with most previous studies and recent references. However, Barekatain et al. used a hypocalcemia threshold of 8 mg/dL in preterm infants (
12).
Total calcium measurements can be misleading when albumin concentrations are abnormal (
14,
23). Ionized calcium is the active fraction of circulating calcium (
24). Ionized calcium, a more accurate indicator, was not measured because of its limited availability at this center and its high cost. This may have led to an underestimation of hypocalcemia. However, the absence of clinical signs of hypocalcemia or QTc prolongation may partially, but not definitively, support the laboratory findings. Pereira et al. found no difference in total calcium levels between the first day and the day of discharge in the two groups, but ionized calcium levels differed significantly before and after phototherapy (
21). Tawfik et al. also found no difference between infants with and without hats despite measuring both total and ionized calcium (
4).
Race, climate, and maternal or infant nutrition may have had protective effects in this study. A total of 83.1% of infants were breastfed (P = 0.412), which may have been protective. Breast milk contains calcium-regulating factors, such as PTH-related peptide. Although breast milk and formula do not differ in calcium content, breast milk provides greater calcium availability to infants. Formula may increase the risk of hypocalcemia because of its higher phosphorus content (
8,
25).
The present findings suggest that head covering had no effect on serum calcium levels. This is consistent with the findings of Bibi and Tawfik (
4) but differs from those of other studies (
1,
10,
15,
16). The hat may not have completely blocked light, as light penetration was not assessed. In addition, light penetration through other areas of the body, such as the back, could circumvent the proposed mechanism, particularly in preterm infants (
10).
The QTc interval is an indicator of abnormal ventricular myocardial repolarization (
26) and can be used as a noninvasive marker for calcium monitoring. In this study, QTc intervals remained within the normal range, with a mean of approximately 426 ms, and no cases of QTc prolongation were observed. Similar studies did not assess QTc intervals. Studies have demonstrated a stronger association between QTc prolongation and declining ionized calcium levels than between QTc prolongation and total calcium levels, supporting ionized calcium as the preferred biochemical marker (
27,
28).
The absence of a between-group difference in bilirubin reduction over 48 hours alleviated concerns that covering the infant's head and neck—which constitute a large proportion of the body surface area, particularly in preterm infants—might reduce phototherapy effectiveness.
Overall, these findings suggest that head covering during phototherapy had no effect on serum calcium levels, QTc intervals, or the prevention of hypocalcemia in term and near-term infants after 48 hours of phototherapy. Thus, under conditions similar to those in this study, including a low-risk population, adequate nutrition, and short-term, controlled phototherapy, routine use of a hat to prevent hypocalcemia is not justified.
5.1. Conclusions
Among icteric infants born at ≥ 35 weeks of gestation, head covering during phototherapy was not associated with a statistically significant difference in total calcium levels or QTc intervals compared with phototherapy without head covering after 48 hours of phototherapy. No clinical or biochemical hypocalcemia was observed in either group. No benefit of routine head covering during phototherapy was detected in similar low-risk populations. Calcium monitoring may nevertheless be considered in high-risk neonates based on their clinical condition.
5.2. Limitations
Limitations included the small sample size, the limited number and unbalanced distribution of preterm infants, the lack of ionized calcium measurements, low-intensity phototherapy, the lack of measurement of light penetration through the hat, and the limited monitoring period.
5.3. Recommendations
Multicenter studies with larger samples; simultaneous measurement of ionized calcium, melatonin, and PTH; longer monitoring periods; standardized evaluation of hats in terms of type, material, and light-blocking capacity; and studies specifically involving preterm infants born at < 35 weeks of gestation may help clarify the role of head covering in preventing hypocalcemia and provide more precise clinical guidance. Meta-analyses and systematic reviews are also recommended to obtain more precise results.